ClinicalTrials.gg
CompletedNCT01016353Updated Dec 2, 2024Results posted

Open Abdomen Study Comparing ABThera™ Open Abdomen Negative Pressure Therapy System and Barker's Vacuum Packing Technique

An observational study in Open Abdomen, sponsored by KCI USA, Inc. Completed at 11 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-12-02.

Sponsored by KCI USA, Inc (part of Solventum) · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
283
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study is being done to gather data that will be used to compare two different TAC (Temporary Abdominal Closure) methods that your doctor may use. The two TAC methods being compared are the Barker's vacuum packing technique or BVPT and the Open Abdomen Negative Pressure Therapy System (ABThera) developed by the sponsor of this research (KCI, San Antonio, TX). The BVPT is made up of supplies that are stocked in most surgery rooms. The ABThera dressing is available commercially. Neither method will be supplied to the doctor (Principal Investigator), so that in no way would the subject's standard of care be different from what they would get if the study was not being done.

This study is observational and only collects data about how the subject progresses after surgery TAC is used. When a study is observational it means that the subject's standard medical care will not be altered in any way, simply watched. The doctor will not change treatment of your open abdomen.

Read the detailed description

This study is being done to gather data that will be used to compare two different TAC (Temporary Abdominal Closure) methods. The two TAC methods being compared are the Barker's vacuum packing technique or BVPT and the Open Abdomen Negative Pressure Therapy System (ABThera) developed by the sponsor of this research (KCI, San Antonio, TX). The BVPT is made up of supplies that are stocked in most surgery rooms. The ABThera dressing is available commercially. Neither method will be supplied to the doctor (Principal Investigator), so that in no way would the subject's standard of care be different from what they would get if the study was not being done.

This study is observational and only collects data about how the subject progresses after surgery TAC is used. When a study is observational it means that the subject's standard medical care will not be altered in any way, simply watched. The doctor will not change treatment of your open abdomen.

02

Conditions studied

  • Open Abdomen

Keywords

  • ABThera
  • Barker's Vacuum Packing Technique
03

In context

Lead sponsor

KCI USA, Inc is the lead sponsor of 18 studies on the registry; none are open to participants now.

First submitted before KCI USA, Inc became part of Solventum.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Emergent Care

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subjects 18-75 years of age
  2. OA Subjects treated with only one of the following TACs at initial placement (defined as the time of the first application of a TAC method):

    1. ABThera
    2. BVPT

Exclusion criteria

Exclusion Criteria:

  1. Pregnant females
  2. Active, uncontrolled hemorrhage at the time of TAC placement
  3. Diagnosis of pre-existing bleeding disorder
  4. Known allergy or hypersensitivity to polyvinyl, polyurethane, acrylic, or acrylic adhesive
  5. Subjects with fistulas
  6. Subjects who have been enrolled in this study previously
  7. Documented history of Child-Pugh Turcot Liver Dysfunction - Class C (10-15 points) at the time of enrollment
  8. Subjects with body mass index (BMI) > 40 as estimated at the time of Emergency Department (ED) or OR admission
  9. Known New York Heart Association Functional Classification - Class IV at the time of enrollment
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
283 participants (actual)

Interventions

  • DeviceNPWT

    ABThera Open Abdomen Negative Pressure Therapy System

    Also known as: ABThera

  • DeviceBVPT

    Barker's Vacuum Packing Technique

06

What researchers measure

Primary outcomes

  1. Number of Participants With Primary Fascial Closure

    Time frame: Up to 30 days

07

Results

Posted Jan 3, 2018

Participant flow

Participant flow — Overall Study
MilestoneNPWTBVPT
Started180103
Completed178102
Not completed21

Outcome measures

PrimaryNumber of Participants With Primary Fascial Closure
Time frame:
Up to 30 days
Reported as:
Count of participants · Participants
Number of Participants With Primary Fascial Closure
ParticipantsNPWTBVPT
Number of Participants With Primary Fascial Closure13969
Statistical analysis
  • NPWT vs BVPT · Log Rank · p = 0.06

Adverse events

Collected over 30 day. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
NPWT21/178 (11.8%)3/180 (1.7%)65/180 (36.1%)
BVPT20/102 (19.6%)0/103 (0%)36/103 (35%)
Most frequent serious events
Most frequent serious events
EventNPWTBVPT
Abdominal Compartment SyndromeGastrointestinal disorders3/1800/103
Most frequent other events
Most frequent other events
EventNPWTBVPT
Intra-Abdominal HypertensionGastrointestinal disorders22/1809/103
Mulitple Organ Dysfunction SyndromeGeneral disorders12/18012/103
SepsisInfections and infestations16/18011/103
Abdominal InfectionInfections and infestations10/18010/103
Loss of Fascial DomainMusculoskeletal and connective tissue disorders14/1809/103
Intraloop AdhesionsGastrointestinal disorders15/1801/103
Gastrointestinal NecrosisGastrointestinal disorders12/1802/103
Abdominal AdhesionsGastrointestinal disorders9/1806/103

Baseline characteristics

Age, Continuous
Age, Continuous(years)NPWTBVPTTotal
Mean40 ± 1739 ± 1640 ± 16
Sex: Female, Male
Sex: Female, Male(Participants)NPWTBVPTTotal
Female362864
Male14274216
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)NPWTBVPTTotal
Race/Ethnicity — American Indian112
Race/Ethnicity — Asian437
Race/Ethnicity — Black or African American544094
Race/Ethnicity — Hispanic or Latino371047
Race/Ethnicity — Native Hawaiian112
Race/Ethnicity — White8147128
Region of Enrollment
Region of Enrollment(Participants)NPWTBVPTTotal
United States178102280
08

Study locations

11 sites
  • University of South Alabama Medical Center
    Mobile, Alabama 36617, United States
  • LAC/USC Medical Center
    Los Angeles, California 90033, United States
  • Orlando Regional Medical Center
    Orlando, Florida 32806, United States
  • Cook County Medical Center
    Chicago, Illinois 60612, United States
  • Tulane Medical Center
    New Orleans, Louisiana 70117, United States
  • University of Maryand
    Baltimore, Maryland 21201, United States
  • University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73117, United States
  • Oregon Health & Science University
    Portland, Oregon 97239, United States
  • Albert Einstein Medical Center
    Philadelphia, Pennsylvania 19006, United States
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
  • Regional Medical Center
    Memphis, Tennessee 38163, United States
09

References and documents

Publications

  • Bjorck M, Kirkpatrick AW, Cheatham M, Kaplan M, Leppaniemi A, De Waele JJ. Amended Classification of the Open Abdomen. Scand J Surg. 2016 Mar;105(1):5-10. doi: 10.1177/1457496916631853. Epub 2016 Feb 29. PubMed 26929286 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01016353
Lead sponsor
KCI USA, Inc
Responsible party
Sponsor
First posted
Nov 19, 2009
Start date
Dec 2009
Primary completion
Jan 2011
Completion
Jan 2011
Results posted
Jan 3, 2018
Last update
Dec 2, 2024

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion